| Financial Year |
March 31 2023 |
| Monetary Funds |
1,149,054,173.93 |
| Held-for-trading Financial Assets |
109,187,721.39 |
| Notes Receivable |
9,667,600.99 |
| Accounts Receivable |
162,916,641.05 |
| Advances to Suppliers |
34,496,514.59 |
| Other Receivables |
14,598,379.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
274,105,064.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,648,097.83 |
| Total Current Assets |
1,768,031,428.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,855,307.41 |
| Investment Properties |
125,928,391.63 |
| Fixed Assetes |
508,589,722.09 |
| Under-construction Projects |
164,849,921.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
140,489,108.35 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
203,831,314.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,391,499.33 |
| Deferred Income Tax Assets |
42,633,595.37 |
| Other Non-Current Assets |
11,022,977.38 |
| Sub-Total of Non-Current Assets |
1,319,758,719.38 |
| Total Assets |
3,087,790,147.71 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,813,000.00 |
| Accounts Payable |
85,522,185.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,637,727.01 |
| Taxes Payable |
11,091,610.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,736,931.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
148,498.83 |
| Other Current Liabilities |
13,330,171.67 |
| Sub-Total of Current Liabilities |
259,454,748.38 |
| Long-term Loans |
-- |
| Bonds Payable |
201,990,083.60 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
28,633,573.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
312,259,389.00 |
| Total Liabilities |
571,714,137.38 |
| Paid-In Capital(Or Share Stock) |
729,596,474.00 |
| Capital Surplus |
480,791,750.78 |
| Surplus Reserve |
211,267,045.64 |
| LESS:Treasury Stock |
100,080,152.68 |
| Undistributed Profits |
1,185,232,091.78 |
| Minority Stockholder's Interest |
8,782,243.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,507,293,766.97 |
| Owner's Equity（Stockholder's Equity） |
2,516,076,010.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,087,790,147.71 |
